Contribute Try STAT+ Today

Stephen Hahn, President Trump’s nominee to helm the Food and Drug Administration, will today face his first real test in Washington — a confirmation hearing packed with hours of questions from senators on nearly every aspect of the agency’s sprawling portfolio, from mysterious vaping illnesses to the promise of gene therapies.

Hahn, who currently serves as the chief medical executive of MD Anderson Cancer Center, is auditioning for the FDA’s top job at a transformational time for the agency.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • I’ have been posting for several years that FDA has been totally unwilling to use its authority to regulate vaping device safety, impose nicotine purity and dosage levels, and make a gesture to ban the sale of devices designed for vaping illicit drugs. As a consequence we have seen needless illness and death – but only in the USA where we have “free markets” (an oxymoron if there ever was one).

Comments are closed.